| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 21, 836-844, Copyright © 1993 by American Heart Association
C Cardillo, F De Felice, U Campia and G Folli
This study aimed 1) to assess whether patients with an exaggerated blood
pressure response to the doctor's presence ("white coat" effect) also
display a pattern of enhanced blood pressure reactivity to mental stress
and physical exercise and 2) to determine the presence of left ventricular
structural and filling abnormalities in patients with white coat
hypertension. We studied 56 (40 men) consecutive patients (mean [SD] age,
46.4 [9.1] years) whose clinic blood pressure was repeatedly high. Patients
were classified as having white coat hypertension (n = 20) if both their
mean daytime (from 7 AM to 11 PM) ambulatory systolic and diastolic blood
pressures were less than 134 and 90 mm Hg, respectively. Patients were
considered to have persistent hypertension (n = 36) if daytime systolic
blood pressure was 134 mm Hg or more or diastolic blood pressure was 90 mm
Hg or more. Eighteen subjects with clinic blood pressure lower than 140/90
mm Hg served as a normotensive control group. Blood pressure reactivity
from baseline to mental arithmetic, isometric handgrip, and cycle ergometry
did not display any difference among the three groups. The white coat
hypertensive group had left ventricular mass index lower than the
persistent hypertensive group but higher than the normotensive group.
Doppler indexes of left ventricular diastolic filling displayed similar
abnormalities in the white coat and persistent hypertensive groups compared
with the normotensive group.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Psychophysiological reactivity and cardiac end-organ changes in white coat hypertension
Istituto di Patologia Medica, Universita Cattolica del Sacro Cuore, Rome, Italy.
This article has been cited by other articles:
![]() |
D Erdogan, H Gullu, M Caliskan, I Yildirim, D Tok, and H Muderrisoglu Coronary flow reserve is preserved in white-coat hypertension Heart, August 1, 2006; 92(8): 1109 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O. Ventura and M. R. Mehra White Coat Hypertension and Sleep Apnea: Is There a Link? Chest, March 1, 2004; 125(3): 805 - 807. [Full Text] [PDF] |
||||
![]() |
P. Verdecchia Prognostic Value of Ambulatory Blood Pressure : Current Evidence and Clinical Implications Hypertension, March 1, 2000; 35(3): 844 - 851. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bellomo, P. L. Narducci, F. Rondoni, G. Pastorelli, G. Stangoni, G. Angeli, and P. Verdecchia Prognostic Value of 24-Hour Blood Pressure in Pregnancy JAMA, October 20, 1999; 282(15): 1447 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. MacDonald, G. P. Laing, M. P. Wilson, and T. W. Wilson Prevalence and predictors of white-coat response in patients with treated hypertension Can. Med. Assoc. J., August 1, 1999; 161(3): 265 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Owens, N. Atkins, and E. O'Brien Diagnosis of White Coat Hypertension by Ambulatory Blood Pressure Monitoring Hypertension, August 1, 1999; 34(2): 267 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Khattar, R. Senior, and A. Lahiri Cardiovascular Outcome in White-Coat Versus Sustained Mild Hypertension : A 10-Year Follow-Up Study Circulation, November 3, 1998; 98(18): 1892 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W Muscholl, H.-W Hense, U. Bröckel, A. Döring, G. A J Riegger, and H. Schunkert Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey BMJ, August 29, 1998; 317(7158): 565 - 570. [Abstract] [Full Text] |
||||
![]() |
S. D. Pierdomenico, F. Costantini, A. Bucci, D. De Cesare, F. Cuccurullo, and A. Mezzetti Low-Density Lipoprotein Oxidation and Vitamins E and C in Sustained and White-Coat Hypertension Hypertension, February 1, 1998; 31(2): 621 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Palatini, P. Mormino, M. Santonastaso, L. Mos, M. Dal Follo, G. Zanata, and A. C. Pessina Target-Organ Damage in Stage I Hypertensive Subjects With White Coat and Sustained Hypertension: Results From the HARVEST Study Hypertension, January 1, 1998; 31(1): 57 - 63. [Abstract] [Full Text] |
||||
![]() |
N.-C. Chang, Z.-Y. Lai, P. Chan, and T.-C. Wang Left Ventricular Filling Profiles in Young White-Coat Hypertensive Patients Without Hypertrophy Hypertension, September 1, 1997; 30(3): 746 - 752. [Abstract] [Full Text] |
||||
![]() |
P. Verdecchia, G. Schillaci, C. Borgioni, A. Ciucci, and C. Porcellati Prognostic Significance of the White Coat Effect Hypertension, June 1, 1997; 29(6): 1218 - 1224. [Abstract] [Full Text] |
||||
![]() |
S. D. Pierdomenico, D. Lapenna, M. D. Guglielmi, T. Antidormi, C. Schiavone, F. Cuccurullo, and A. Mezzetti Target Organ Status and Serum Lipids in Patients With White Coat Hypertension Hypertension, November 1, 1995; 26(5): 801 - 807. [Abstract] [Full Text] |
||||
![]() |
M. C. Cavallini, M. J. Roman, T. G. Pickering, J. E. Schwartz, R. Pini, and R. B. Devereux Is White Coat Hypertension Associated With Arterial Disease or Left Ventricular Hypertrophy? Hypertension, September 1, 1995; 26(3): 413 - 419. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |